PETER P. PFREUNDSCHUH

CIK 1585839 · EVP, CFO and Treasurer · last filed 2025-09-18

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$966.4K

Companies

6

Total Filings

33

Lifetime Open-Market Net

-$317.2K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Y-mAbs Therapeutics, Inc. (YMAB) Delisted CFO and Treasurer 77,800 $8.61 $669.9K $0 2 2025-01-22
VYGR Chief Financial Officer 175,669 $3.50 $614.8K -$122.9K 6 2024-02-22
Korro Bio, Inc. (FREQ) Delisted Chief Financial Officer 10,469 $14.98 $156.8K -$27.6K 6 2022-02-23
URGN Chief Financial Officer 11,829 $29.72 $351.6K -$166.7K 11 2020-10-16
Sucampo Pharmaceuticals, Inc. (SCMP) Delisted CFO 0 $0 3 2018-02-13
IMMUNOMEDICS INC (IMMU) Delisted Chief Financial Officer 29,706 $0 4 2015-08-24

Recent Filings · Page 4 of 4

33 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2015-03-11 IMMUNOMEDICS INC (IMMU) Delisted Grant (A) $0 EDGAR
2014-08-18 IMMUNOMEDICS INC (IMMU) Delisted Grant (A) +15,813 $0 EDGAR
2013-09-04 IMMUNOMEDICS INC (IMMU) Delisted Grant (A) $0 EDGAR
Showing 3133 of 33
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.